What's Hot

    Global stocks surge as US debt ceiling agreement brings relief

    May 29, 2023

    India’s mastery in space: ISRO’s successful launch of Cartosat-3 satellite

    May 29, 2023

    Global clean energy investment set to reach $1.7 trillion, overtaking oil production

    May 27, 2023
    Facebook Twitter Instagram
    • Home
    • Contact Us
    Ghana BulletinGhana Bulletin
    • Automotive
    • Business
    • Entertainment
    • Health
    • Lifestyle
    • Luxury
    • News
    • Sports
    • Technology
    • Travel
    Ghana BulletinGhana Bulletin
    Home » New study highlights potential of Pfizer’s oral weight loss drug as alternative to Ozempic
    Health

    New study highlights potential of Pfizer’s oral weight loss drug as alternative to Ozempic

    May 22, 2023
    Facebook Twitter Pinterest LinkedIn Tumblr Email

    A peer-reviewed study released on Monday reveals that an oral weight loss drug developed by Pfizer demonstrates similar efficacy and faster results compared to Novo Nordisk’s Ozempic injection. The phase two clinical trial included 411 adults with Type 2 diabetes who were either given Pfizer’s pill, danuglipron, twice a day or a placebo. The study found that patients who took a 120-milligram dosage of danuglipron lost an average of 10 pounds (4.60 kilograms) over a 16-week period.

    New study highlights potential of Pfizer's oral weight loss drug as alternative to Ozempic

    In comparison, a phase three clinical trial on Ozempic showed that adults using a 1-milligram injection lost an average of 9.9 pounds (4.53 kilograms) over 30 weeks. The results suggest that Pfizer’s drug may be equally effective for weight loss as Ozempic, while offering the advantage of being an oral treatment option rather than an injection. Both danuglipron and Ozempic are glucagon-like peptide-1 antagonists, belonging to a class of drugs that mimic a gut hormone called GLP-1, signaling fullness to the brain. These drugs are also beneficial in managing Type 2 diabetes by promoting insulin release and reducing blood sugar levels.

    Pfizer’s entry into the weight loss drug market comes as Novo Nordisk’s Ozempic and Wegovy have gained attention for their weight loss effects. These drugs have been sought after by celebrities, social media influencers, and even Elon Musk for shedding unwanted weight. However, concerns have been raised about the perpetuation of a dangerous diet culture that prioritizes weight loss and thinness. Additionally, some patients who discontinue these drugs experience difficulty in controlling weight rebound.

    With over 2 in 5 adults having obesity and 1 in 11 adults having severe obesity, the search for effective weight loss solutions has become a priority for public health authorities and pharmaceutical companies. Pfizer’s promising results from the clinical trial provide hope for an alternative oral treatment option that could potentially address the global obesity epidemic more conveniently. Further research and development will be necessary to assess the long-term effectiveness and safety of Pfizer’s weight loss drug and its potential impact on individuals struggling with obesity.

    Share. Facebook Twitter Pinterest LinkedIn Tumblr Email

    Related Posts

    Resting heart rate: The overlooked metric in cardiac health assessment

    May 25, 2023

    Global healthcare experts gather in Dubai for PMES 2023

    May 23, 2023

    African leaders commit to ending AIDS among children by 2030

    February 2, 2023

    Feds say Florida nursing schools sold 7,600 fake diplomas

    January 28, 2023
    Latest News

    Global stocks surge as US debt ceiling agreement brings relief

    May 29, 2023

    India’s mastery in space: ISRO’s successful launch of Cartosat-3 satellite

    May 29, 2023

    Global clean energy investment set to reach $1.7 trillion, overtaking oil production

    May 27, 2023

    European Investment Bank supports circular economy with €3.4 billion lending

    May 27, 2023

    WHO report urges governments: prioritize food security over tobacco industry

    May 27, 2023

    Successful UAE-India partnership stands as a model of bilateral cooperation

    May 27, 2023

    India soaring to new heights: the impact of nine years of Modi’s leadership

    May 25, 2023

    Tina Turner passes, but her music forever echoes in the heart of rock’n’roll

    May 25, 2023
    © 2021 Ghana Bulletin | All Rights Reserved
    • Home
    • Contact Us

    Type above and press Enter to search. Press Esc to cancel.